-
1
<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
Published 2012-11-01Subjects: Get full text
Article -
2
Gastroesophageal reflux disease, resistant to proton pump inhibitors
Published 2011-06-01Subjects: Get full text
Article -
3
Pharmaceutical hemostasis at peptic ulcer bleeding: state-of-the-art and perspectives
Published 2013-07-01Subjects: Get full text
Article -
4
Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
Published 2022-05-01Subjects: Get full text
Article -
5
Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week)
Published 2020-12-01Subjects: Get full text
Article -
6
Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells
Published 2020-06-01Subjects: “…proton pump inhibitors…”
Get full text
Article -
7
Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
Published 2015-12-01Subjects: Get full text
Article -
8
Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system: comparing public and private prescribing
Published 2025-01-01Subjects: “…Proton-pump inhibitors…”
Get full text
Article -
9
The role of pH in symptomatic relief and effective treatment of gastroesophageal reflux disease
Published 2017-12-01Subjects: Get full text
Article -
10
Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
Published 2015-05-01Subjects: Get full text
Article -
11
Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review
Published 2022-08-01Subjects: Get full text
Article -
12
Predictive Factors Associated with Inappropriate Intravenous Proton Pump Inhibitors Use in Hospitalized Patients: A Case-Control Study
Published 2024-12-01Subjects: Get full text
Article -
13
Vonoprazan in the management of erosive oesophagitis and peptic ulcer-induced medication: a systematic review
Published 2021-12-01Subjects: Get full text
Article -
14
Histamine 2 receptor antagonists do not improve the outcomes of hospitalized COVID-19 patients
Published 2021-07-01Subjects: Get full text
Article -
15
New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
Published 2014-11-01Subjects: Get full text
Article -
16
Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial
Published 2025-01-01Subjects: “…proton pump inhibitors…”
Get full text
Article -
17
Consumption of proton pump inhibitors in outpatients of Gastroenterology Clinics in Khyber Pakhtunkhwa: evidence of inexpedient use
Published 2024-05-01Subjects: Get full text
Article -
18
Potentials of 24-hour esophageal рН monitoring in diagnostics and treatment efficacy control of gastroesophageal reflux disease
Published 2012-02-01Subjects: “…gastroesophageal reflux disease, 24-hour intraesophageal ph-metry, proton pump inhibitors (ppi)…”
Get full text
Article -
19
How to Make the Right Choice of Proton Pump Inhibitor for Patients with Gastroesophageal Reflux Disease?
Published 2023-06-01Subjects: Get full text
Article -
20